API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-subsidiary-aleor-dermaceuticals-gets-usfda-nod-for-acne-gel/93423857
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214185
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209641
https://www.expresspharma.in/zydus-lifesciences-receives-final-approval-from-us-fda-for-adapalene-and-benzoyl-peroxide-topical-gel/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214553
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215940
https://www.business-standard.com/article/companies/zydus-cadila-gets-tentative-nod-from-usfda-to-market-generic-acne-drug-121100800461_1.html
https://www.fiercepharma.com/marketing/galderma-tackles-maskne-one-many-skin-health-concerns-exploding-during-pandemic
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213508
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208108
https://www.business-standard.com/article/news-cm/glenmark-pharma-rises-after-usfda-nod-for-generic-acne-treatment-gel-119111100800_1.html
https://www.fiercepharma.com/manufacturing/tergus-pharma-to-become-full-fledged-cdmo-new-manufacturing-facility
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209148
https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206164
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205033
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206959
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-generic-version-of-epiduo-gel-300321435.html
http://www.prnewswire.com/news-releases/galderma-announces-fda-approval-of-full-prescription-strength-differin-gel-for-over-the-counter-acne-use-300295931.html
https://www.pharmacompass.com/pdf/news/taro-pharmaceuticals-generic-adapalene-approved-in-us-for-acne-1467204512.pdf
http://www.reuters.com/article/2015/11/13/us-healthcare-pharmacies-irmat-idUSKCN0T22HT20151113
https://www.pharmacompass.com/pdf/news/actavis-generic-adapalene-and-benzoyl-peroxide-approved-in-us-for-acne-1443791385.pdf
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/report-card-fda-gets-a-solid-b-on-timely-responding-to-section-505w-discontinuation-citizen-petition.html